HYTN Awarded Drug Establishment License from Health Canada, Expanding GMP Capabilities
“One of the very few companies globally to achieve these certifications” VANCOUVER, British Columbia, June 27, 2024 (GLOBE NEWSWIRE) — HYTN Innovations Inc. (CSE: HYTN | FSE: 85W0) “HYTN” or “The Company”, a leader in the development, formulation, and manufac…
Author of the article:
Article content
One of the very few companies globally to achieve these certifications
VANCOUVER, British Columbia, June 27, 2024 (GLOBE NEWSWIRE) HYTN Innovations Inc. (CSE…